Journal of Clinical Microbiology · 2009 · 130 citations · 78 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMycologyAntibiotic ResistanceAntifungal ResistanceAntimicrobial Susceptibility TestingBloodstream InfectionsFungal InfectionsResistance EpidemiologyAntibiotic Resistance In Bloodstream IsolatesAntifungal Susceptibility TestingFluconazole TherapyFungal Drug ResistanceGeographic RegionsResistance In Clinical Isolates
We examined the susceptibilities to fluconazole of 642 bloodstream infection (BSI) isolates of Candida glabrata and grouped the isolates by patient age and geographic location within the United States. Susceptibility of C. glabrata to fluconazole was lowest in the northeast region (46%) and was highest in the west (76%). The frequencies of isolation and of fluconazole resistance among C. glabrata BSI isolates were higher in the present study (years 2001 to 2007) than in a previous study conducted from 1992 to 2001. Whereas the frequency of C. glabrata increased with patient age, the rate of fluconazole resistance declined. The oldest age group (> or = 80 years) had the highest proportion of BSI isolates that were C. glabrata (32%) and the lowest rate of fluconazole resistance (5%).
78
Guidelines for Treatment of Candidiasis
Peter G. Pappas, John Rex, Jack D. Sobel et al. · Clinical Infectious Diseases · 2004 · 1.4K citations · Full text
Matthew R. Morrell, Victoria J. Fraser, Marin H. Kollef · Antimicrobial Agents and Chemotherapy · 2005 · 1.3K citations · Full text